JPH05105643A - Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component - Google Patents

Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component

Info

Publication number
JPH05105643A
JPH05105643A JP26640891A JP26640891A JPH05105643A JP H05105643 A JPH05105643 A JP H05105643A JP 26640891 A JP26640891 A JP 26640891A JP 26640891 A JP26640891 A JP 26640891A JP H05105643 A JPH05105643 A JP H05105643A
Authority
JP
Japan
Prior art keywords
skin
cosmetic
derivative
methoxycinnamic acid
acetoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP26640891A
Other languages
Japanese (ja)
Inventor
Hiroaki Onuma
寛明 大沼
Yoshinori Nishizawa
義則 西澤
Hiroko Jokura
博子 城倉
Takeshi Kobayashi
剛 小林
Genji Imokawa
玄爾 芋川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP26640891A priority Critical patent/JPH05105643A/en
Publication of JPH05105643A publication Critical patent/JPH05105643A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To provide a safe skin-beautifying cosmetic having excellent pigmentation improving effect and effective for treating and improving the pigmented part such as spots, freckles and sunburnt skin to the normal skin color by topically applying the cosmetic to the pigmented part. CONSTITUTION:A cinnamic acid derivative of formula (R1 is H or lower acyl; R2 is lower alkyl; R3 is H or lower alkyl), preferably 4-hydroxy-2'- methoxycinnamic acid, 4-acetoxy-2-methoxycinnamic acid or their ester, etc., especially 4-acetoxy-2-methoxycinnamic acid ethyl ester is compounded to a skin-beautifying cosmetic as an active component in an amount of preferably 0.01-50wt.%, especially 0.1-20wt.% to obtain the objective skin-beautifying cosmetic having the above effect different from conventional sun-screening agent to prevent the sunburn. The cosmetic is free from irritation to the skin and development of allergy, etc., and has high safety. The preferable amount of the active component per 1cm<2> of the skin is 1-20mg for creamy or ointment preparation and 1-10mg for liquid preparation.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、安全でかつ色素沈着改
善効果に優れた美白化粧料及びその有効成分である新規
な桂皮酸誘導体に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic which is safe and has an excellent pigmentation improving effect, and a novel cinnamic acid derivative which is an active ingredient thereof.

【0002】[0002]

【従来の技術】しみ、そばかすおよび日焼け後の色素沈
着は、加齢に伴い発生、増加あるいは消失しにくくな
り、中高年齢層の肌の悩みとなっている。これらの色素
沈着症の発症機構は、未だ明確にはされていないが、太
陽光線、特に紫外線や、メラノサイト刺激ホルモン等の
作用により、表皮メラノサイトでのメラニン合成機能が
亢進したためと考えられる。また、表皮角化細胞(ケラ
チノサイト)の加齢に伴う角化遅延化も、表皮外への排
泄速度を遅延させ、メラニン合成能の亢進と合わせて、
表皮内のメラニン顆粒密度の増加、即ち臨床的に色素沈
着が増加する症状を発現するものと考えられる。更にそ
れらの色素沈着部は局部的に存在し、周囲の正常皮膚色
と明らかに差異が生ずることより、メラノサイトの局部
的なメラニン合成亢進、あるいはメラノサイトのメラニ
ン合成をコントロールする機構を変調せしめた結果とも
考えられる。
2. Description of the Related Art Stain, freckles and pigmentation after sunburn are less likely to occur, increase or disappear with ageing, which is a problem for the skin of middle-aged and older people. Although the mechanism of the onset of these pigmentation disorders has not been clarified yet, it is considered that the melanin synthesis function in epidermal melanocytes is enhanced by the action of sunlight, particularly ultraviolet rays, and melanocyte-stimulating hormone. In addition, delayed keratinization with aging of epidermal keratinocytes (keratinocytes) also delays the rate of excretion outside the epidermis, and together with the enhancement of melanin synthesis ability,
It is considered that an increase in melanin granule density in the epidermis, that is, a symptom of clinically increasing pigmentation is manifested. Furthermore, because these pigmented areas are locally present and are clearly different from the surrounding normal skin color, the result is that the mechanism that controls the local melanin synthesis enhancement of melanocytes or the melanin synthesis of melanocytes is modulated. You might also say that.

【0003】これらの後天的な色素、即ちメラニンの沈
着部を正常な皮膚色にまで回復させる薬剤が強く望まれ
ており、これまでにも多くの薬剤が開発され商品化され
てきた。例えば、近年、優れた還元能を有するビタミン
C(L-アスコルビン酸)誘導体を用いた化粧料も用いら
れてきたが、安定性に難があるとともに、外用では効果
がほとんど認められないのが現状であった。
There is a strong demand for a drug that restores these acquired pigments, that is, the melanin deposits to a normal skin color, and many drugs have been developed and commercialized. For example, in recent years, cosmetics using a vitamin C (L-ascorbic acid) derivative having an excellent reducing ability have been used, but it is difficult to be stable and almost no effect is observed when used externally. Met.

【0004】一方、欧米において、ハイドロキノンがし
みの治療や黒人皮膚を白くする等の薬剤として用いられ
ているが、これも物質自体の安全性(刺激性、アレルギ
ー性)に問題があり、また白斑を生じさせるケースもあ
るなどの点から薬剤として配合することには問題があ
る。その他にも種々のメラニン抑制剤が報告されている
が、桂皮酸誘導体としては、p-ヒドロキシ桂皮酸(Bru
n, J. Soc. Cosmet. Chem., 25, 61(1974))やp-ヒドロ
キシ桂皮酸アミド誘導体(特開昭62-56459号公報)が知
られている。しかしながら、色素沈着改善効果及び皮膚
に対する安全性の両者を充分満足する物質は知られてい
ないのが現状である。
On the other hand, in Europe and America, hydroquinone is used as a drug for treating spots and whitening black skin, but this also has a problem in the safety (irritation and allergenicity) of the substance itself, and vitiligo. In some cases, there is a problem in that it is compounded as a drug. Various other melanin inhibitors have been reported, but as a cinnamic acid derivative, p-hydroxycinnamic acid (Bru
n, J. Soc. Cosmet. Chem., 25, 61 (1974)) and p-hydroxycinnamic acid amide derivative (JP-A-62-56459). However, at present, no substance is known that sufficiently satisfies both the pigmentation improving effect and the safety to the skin.

【0005】[0005]

【発明が解決しようとする課題】本発明は、安全でかつ
色素沈着改善効果に優れた美白化粧料を提供することを
目的とする。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a whitening cosmetic which is safe and has an excellent pigmentation improving effect.

【0006】[0006]

【課題を解決するための手段】本発明者らは、メラニン
生成機構の研究を通して色素沈着を減少あるいは消失さ
せる物質を得るべく鋭意検討した結果、特定の桂皮酸誘
導体はメラニン生成抑制作用を有し、しかも皮膚に対す
る刺激性、アレルギーの発現等が認められないことを見
出し、本発明を完成した。
[Means for Solving the Problems] As a result of intensive investigations by the present inventors to obtain a substance that reduces or eliminates pigmentation through research on the mechanism of melanin production, a specific cinnamic acid derivative has a melanin production inhibitory action. Furthermore, they have found that no irritation to the skin, no expression of allergies, etc. are found, and the present invention has been completed.

【0007】すなわち、本発明は次の一般式(1)That is, the present invention has the following general formula (1)

【0008】[0008]

【化3】 [Chemical 3]

【0009】(式中、R1は水素原子または低級アシル
基を、R2は低級アルキル基を、R3は水素原子または低
級アルキル基を示す)で表わされる桂皮酸誘導体を有効
成分とする美白化粧料を提供するものである。
A whitening agent containing a cinnamic acid derivative represented by the formula (wherein R 1 is a hydrogen atom or a lower acyl group, R 2 is a lower alkyl group, and R 3 is a hydrogen atom or a lower alkyl group) as an active ingredient. It is to provide cosmetics.

【0010】また、その有効成分のうち、一般式(2)Among the active ingredients, the general formula (2)

【0011】[0011]

【化4】 [Chemical 4]

【0012】(式中、R1′は低級アシル基を、R2およ
びR3は上記と同様の意味を有する)で表わされる桂皮
酸誘導体をも提供するものである。
A cinnamic acid derivative represented by the formula ( 1) wherein R 1 ′ is a lower acyl group and R 2 and R 3 have the same meanings as described above is also provided.

【0013】本発明において用いられる桂皮酸誘導体
(1)としては、例えば、4-ヒドロキシ-2-メトキシ桂皮酸
またはそのエステル、4-アセトキシ-2-メトキシ桂皮酸
またはそのエステルなどが好ましいものとして挙げられ
る。特に好適な化合物としては、4-アセトキシ-2-メト
キシ桂皮酸エチルエステルを挙げることができる。
Cinnamic acid derivatives used in the present invention
Preferred examples of (1) include 4-hydroxy-2-methoxycinnamic acid or its ester and 4-acetoxy-2-methoxycinnamic acid or its ester. As a particularly suitable compound, 4-acetoxy-2-methoxycinnamic acid ethyl ester can be mentioned.

【0014】本発明の桂皮酸誘導体(1)は、文献記載の
方法に従って、あるいはそれに準じて合成でき、例え
ば、4-ヒドロキシ-2-メトキシベンズアルデヒド系化合
物とマロン酸またはそのエステルをピリジン等の塩基の
存在下で縮合させ、必要に応じて加水分解および(また
は)慣用の方法で誘導体に転化させる方法、4-ヒドロキ
シ-2-メトキシベンズアルデヒド系化合物と(カルベト
キシメチレン)トリフェニルフォスフォラン等のウィテ
ィッヒ試薬を縮合させ、必要に応じて加水分解および
(または)慣用の方法で誘導体に転化させる方法等によ
って容易に得ることができる。
The cinnamic acid derivative (1) of the present invention can be synthesized according to the method described in the literature or in accordance therewith, and, for example, a 4-hydroxy-2-methoxybenzaldehyde compound and malonic acid or its ester are combined with a base such as pyridine. Condensation in the presence of, and optionally hydrolysis and / or conversion to derivatives by conventional methods, such as 4-hydroxy-2-methoxybenzaldehyde compounds and (carbetoxymethylene) triphenylphosphorane with Wittig It can be easily obtained by, for example, condensing a reagent, and if necessary, by hydrolysis and / or converting it into a derivative by a conventional method.

【0015】本発明の美白化粧料には、上記桂皮酸誘導
体(1)を、単独で、または二種以上を組み合わせて配合
することができ、その配合量は、組成物中に0.01〜50重
量%、好ましくは0.1〜20重量%が好ましい。
In the whitening cosmetic composition of the present invention, the cinnamic acid derivative (1) can be blended alone or in combination of two or more, and the blending amount is 0.01 to 50% by weight in the composition. %, Preferably 0.1 to 20% by weight.

【0016】本発明の美白化粧料は、種々の形態にする
ことができるが、一般には、ローション状、乳液状、ク
リーム状、軟膏状、スティック状、有機溶媒による溶液
状、パック状、ゲル状等の化粧料とするのが好ましい。
The whitening cosmetic composition of the present invention can be made into various forms, but in general, it is generally a lotion, an emulsion, a cream, an ointment, a stick, a solution with an organic solvent, a pack, or a gel. It is preferable to use such cosmetics.

【0017】本発明の美白化粧料には、本発明の効果を
損ねない範囲で桂皮酸誘導体(1)以外の任意の成分を配
合することができ、その剤型に応じて、化粧料に通常配
合される成分、例えば精製水、エタノール、油性物質、
保湿剤、増粘剤、防腐剤、乳化剤、薬効成分、粉体、香
料、乳化安定剤、pH調整剤等を配合することができる。
具体的には、油性成分としては流動パラフィン、ワセリ
ン、パラフィンワックス、スクワラン、ミツロウ、カル
ナウバロウ、オリーブ油、ラノリン、高級アルコール、
脂肪酸、高級アルコールと脂肪酸の合成エステル油、シ
リコーン油等が挙げられ、保湿剤としてはソルビトー
ル、キシリトール、グリセリン、マルチトール、プロピ
レングリコール、1,3-ブチレングリコール、1,4-ブチレ
ングリコール、ピロリドンカルボン酸ナトリウム、乳
酸、乳酸ナトリウム、ポリオキシプロピレン脂肪酸エス
テル、ポリエチレングリコール等が挙げられ、増粘剤と
してはカルボキシビニルポリマー、カルボキシメチルセ
ルロース、ポリビニルアルコール、カラギーナン、ゼラ
チン等の水溶性高分子、塩化ナトリウム、塩化カリウム
等の電解質などが挙げられ、防腐剤としては尿素、メチ
ルパラベン、エチルパラベン、プロピルパラベン、ブチ
ルパラベン、安息香酸ナトリウム等が挙げられ、乳化剤
としてはポリオキシエチレンアルキルエーテル、ポリオ
キシエチレン脂肪酸エステル、ポリオキシエチレンソル
ビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポ
リグリセリン脂肪酸エステル、ポリオキシエチレングリ
セリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ
油、ポリオキシエチレンソルビトール脂肪酸エステル等
の非イオン界面活性剤が挙げられ、粉体としてはタル
ク、セリサイト、マイカ、カオリン、シリカ、ベントナ
イト、バーミキュライト、亜鉛華、雲母、雲母チタン、
酸化チタン、酸化マグネシウム、酸化ジルコニウム、硫
酸バリウム、ベンガラ、酸化鉄、群青等が挙げられ、pH
調整剤としては乳酸−乳酸ナトリウム、クエン酸−クエ
ン酸ナトリウム等の緩衝剤が挙げられる。また種々の有
効成分として、アラントイン、ビタミンEアセテート、
グリチルリチン、ヨクイニン、各種植物抽出物等を添加
することにより、メラニン抑制効果の向上を図ることが
できる。更に、種々の紫外線吸収物質を添加することに
より、日焼けの予防効果と治療効果を兼ね備えた化粧料
とすることもできる。
The whitening cosmetic composition of the present invention may contain any component other than the cinnamic acid derivative (1) within a range that does not impair the effects of the present invention. Ingredients such as purified water, ethanol, oily substance,
Moisturizers, thickeners, preservatives, emulsifiers, medicinal ingredients, powders, fragrances, emulsion stabilizers, pH adjusters and the like can be added.
Specifically, as the oil component, liquid paraffin, petrolatum, paraffin wax, squalane, beeswax, carnauba wax, olive oil, lanolin, higher alcohols,
Fatty acids, synthetic ester oils of higher alcohols and fatty acids, silicone oils and the like can be mentioned. Moisturizing agents include sorbitol, xylitol, glycerin, maltitol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, pyrrolidone carboxylic acid. Sodium acid, lactic acid, sodium lactate, polyoxypropylene fatty acid ester, polyethylene glycol and the like can be mentioned. As the thickener, carboxyvinyl polymer, carboxymethyl cellulose, polyvinyl alcohol, carrageenan, water-soluble polymer such as gelatin, sodium chloride, chloride and the like. Examples include electrolytes such as potassium, and examples of preservatives include urea, methylparaben, ethylparaben, propylparaben, butylparaben, sodium benzoate, and the like. Nonionics such as alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitol fatty acid ester Surfactants can be mentioned, and powders include talc, sericite, mica, kaolin, silica, bentonite, vermiculite, zinc white, mica, titanium mica,
Examples include titanium oxide, magnesium oxide, zirconium oxide, barium sulfate, red iron oxide, iron oxide, ultramarine blue, and the like.
Examples of the adjusting agent include buffers such as lactic acid-sodium lactate and citric acid-sodium citrate. Also, as various active ingredients, allantoin, vitamin E acetate,
By adding glycyrrhizin, yoquinin, various plant extracts and the like, the melanin suppressing effect can be improved. Further, by adding various ultraviolet absorbing substances, it is possible to obtain a cosmetic having both a sunburn preventing effect and a sunburn preventing effect.

【0018】本発明の美白化粧料は、紫外線による皮膚
の炎症、しみ、そばかす、日焼け後の色素沈着部等の患
部に局所的に適用することにより、該部位を治療・改善
し、正常な皮膚色に戻すことができる。また、一般にそ
の用量は、例えばクリーム状又は軟膏状の製剤の場合、
皮膚面1cm2当り1〜20mg、液状製剤の場合、同じく1
〜10mgとするのが好ましい。
The whitening cosmetic composition of the present invention can be applied to the affected areas such as skin inflammation caused by ultraviolet rays, stains, freckles, and pigmented areas after sunburn to treat / improve the affected areas to obtain normal skin. Can be returned to color. Generally, the dose is, for example, in the case of a cream or ointment type preparation,
1 to 20 mg per cm 2 of skin surface, the same for liquid formulations 1
It is preferably about 10 mg.

【0019】[0019]

【実施例】次に、実施例および参考例をあげて本発明を
説明する。
EXAMPLES Next, the present invention will be described with reference to examples and reference examples.

【0020】参考例1 4-ヒドロキシ-2-メトキシ桂皮酸エチルエステルの合
成:4-ヒドロキシ-2-メトキシベンズアルデヒド0.5g
(3.3mmol)をベンゼン23mlに溶かし、室温下(カルベ
トキシメチレン)トリフェニルフォスフォラン1.64g
(4.7mmol)を1時間かけて加え、その状態で3時間撹
拌を続けた。反応終了後、ベンゼンをエバポレーターで
留去したのち、残留物をカラムクロマトグラフィ(シリ
カゲル)にかけて精製し、粗精製物0.7gを得た。これ
を水−エタノールより再結晶化し、融点143.1〜146.0℃
の白色針状晶として4-ヒドロキシ-2-メトキシ桂皮酸エ
チルエステル496mg(2.2mmol)を得た(収率68%)。 IR(KBr,cm-1) 3364(s), 3080, 2980, 2944, 1682(s),1610(s), 1582
(s), 1480, 1436,1372, 1350, 1312(s), 1286, 1238, 1
186(s),1168, 1112, 1038, 988,960, 860, 800, 672, 6
52, 518, 4701 H-NMR(CDCl3+D2O,TMS,δ) 7.90(1H,d,J=16.1Hz), 7.37(1H,d,J=9.0Hz), 6.5-6.3(3
H),4.25(2H,q,J=7.2Hz), 3.85(3H,s), 1.33(3H,t,J=7.2
Hz),
Reference Example 1 Synthesis of 4-hydroxy-2-methoxycinnamic acid ethyl ester: 0.5 g of 4-hydroxy-2-methoxybenzaldehyde
(3.3 mmol) was dissolved in 23 ml of benzene, and 1.64 g of triphenylphosphorane at room temperature (carbetoxymethylene)
(4.7 mmol) was added over 1 hour, and stirring was continued in that state for 3 hours. After completion of the reaction, benzene was distilled off with an evaporator, and the residue was purified by column chromatography (silica gel) to obtain 0.7 g of a crude product. This was recrystallized from water-ethanol and had a melting point of 143.1 to 146.0 ° C.
As a white needle crystal, 496 mg (2.2 mmol) of 4-hydroxy-2-methoxycinnamic acid ethyl ester was obtained (68% yield). IR (KBr, cm -1 ) 3364 (s), 3080, 2980, 2944, 1682 (s), 1610 (s), 1582
(s), 1480, 1436, 1372, 1350, 1312 (s), 1286, 1238, 1
186 (s), 1168, 1112, 1038, 988,960, 860, 800, 672, 6
52, 518, 470 1 H-NMR (CDCl 3 + D 2 O, TMS, δ) 7.90 (1H, d, J = 16.1Hz), 7.37 (1H, d, J = 9.0Hz), 6.5-6.3 (3
H), 4.25 (2H, q, J = 7.2Hz), 3.85 (3H, s), 1.33 (3H, t, J = 7.2
Hz),

【0021】実施例1 4-アセトキシ-2-メトキシ桂皮酸エチルエステルの合
成:4-ヒドロキシ-2-メトキシ桂皮酸エチルエステル300
mg(1.35mmol)、無水酢酸220mg(2.15mmol)とピリジ
ン1.07gの混合物を室温で一晩撹拌した。これに水10ml
を加え、酢酸エチル20mlで2回抽出し、硫酸マグネシウ
ムで乾燥した。溶媒をエバポレーターで留去したのち、
残留物をカラムクロマトグラフィー(SiO2,ヘキサン/
酢酸エチル=5)にかけて精製し、融点56.4〜57.0℃の
白色結晶として4-アセトキシ-2-メトキシ桂皮酸エチル
エステル341mg(1.29mmol)を得た(収率96%)。1 H-NMR(CDCl3,TMS,δ) 7.92(1H,d,J=16.1Hz), 7.50(1H,d,J=8.3Hz), 6.8-6.6(2
H),6.49(1H,d,J=16.1Hz), 4.26(1H,q,J=7.2Hz), 3.87(3
H,s),2.31(3H,s),1.33(3H,t,J=7.2Hz)
Example 1 Synthesis of 4-acetoxy-2-methoxycinnamic acid ethyl ester: 4-hydroxy-2-methoxycinnamic acid ethyl ester 300
A mixture of mg (1.35 mmol), acetic anhydride 220 mg (2.15 mmol) and pyridine 1.07 g was stirred overnight at room temperature. 10 ml of water to this
Was added thereto, extracted twice with 20 ml of ethyl acetate, and dried over magnesium sulfate. After distilling off the solvent with an evaporator,
The residue was subjected to column chromatography (SiO 2 , hexane /
The product was purified with ethyl acetate = 5) to obtain 341 mg (1.29 mmol) of 4-acetoxy-2-methoxycinnamic acid ethyl ester as white crystals having a melting point of 56.4 to 57.0 ° C (yield 96%). 1 H-NMR (CDCl 3 , TMS, δ) 7.92 (1H, d, J = 16.1Hz), 7.50 (1H, d, J = 8.3Hz), 6.8-6.6 (2
H), 6.49 (1H, d, J = 16.1Hz), 4.26 (1H, q, J = 7.2Hz), 3.87 (3
H, s), 2.31 (3H, s), 1.33 (3H, t, J = 7.2Hz)

【0022】実施例2 4-アセトキシ-2-メトキシ桂皮酸及び4-ヒドロキシ-2-メ
トキシ桂皮酸の合成:4-アセトキシ-2-メトキシベンズ
アルデヒド0.86g(4.43mmol)、マロン酸1.15g(11.1
mmol)、ピリジン4mlおよびピペリジン1滴の混合物を
1.5時間加熱撹拌した。冷却後、水30mlを加えて30分間
撹拌後、析出した結晶を濾取した。第1晶からは、融点
187.1〜193.4℃の白色結晶として4-アセトキシ-2-メト
キシ桂皮酸295mg(1.25mmol)を得た(収率28%)。1 H-NMR(DMSOd6,TMS,δ) 12.34(1H,brs), 7.78(1H,d,J=16.1Hz),7.72(1H,d,J=8.5
Hz), 6.91(1H,s),6.77(1H,d,J=8.5Hz), 6.50(1H,d,J=1
6.1Hz), 3.85(3H,s), 2.28(3H,s) また、第2晶からは、4-アセトキシ-2-メトキシ桂皮酸
と4-ヒドロキシ-2-メトキシ桂皮酸の混合物399mgを得
た。続いて、この混合物399mgとナトリウムメチラート2
00mg(3.70mmol)のメタノール溶液を30分間加熱撹拌し
た。冷却後、飽和塩化アンモニウム水溶液を加えて酸性
にしたのち、テトラヒドロフラン20mlで抽出した。溶媒
をエバポレーターで留去したのち、エーテルに溶解し、
飽和炭酸水素ナトリウム水溶液を加え有機層を分離し
た。水層に希塩酸を加えて酸性にしたのち、析出した黄
緑色結晶を濾取した。これを水−アセトンより再結晶化
し、融点165.5〜167.5℃(分解)の微黄色粉末として4-
ヒドロキシ-2-メトキシ桂皮酸114.6mg(0.52mmol)を得
た(収率は4-アセトキシ-2-メトキシベンズアルデヒド
に対して12%)。1 H-NMR(DMSOd6,TMS,δ) 10.12(1H,brs), 7.73(1H,d,J=16.1Hz),7.49(1H,d,J=8.3
Hz), 6.44(1H,s),6.40(1H,d,J=8.3Hz), 6.29(1H,d,J=1
6.1Hz), 3.80(3H,s)
Example 2 Synthesis of 4-acetoxy-2-methoxycinnamic acid and 4-hydroxy-2-methoxycinnamic acid: 4-acetoxy-2-methoxybenzaldehyde 0.86 g (4.43 mmol), malonic acid 1.15 g (11.1
mmol), 4 ml of pyridine and 1 drop of piperidine
The mixture was heated and stirred for 1.5 hours. After cooling, 30 ml of water was added and the mixture was stirred for 30 minutes, then the precipitated crystals were collected by filtration. Melting point from the first crystal
295 mg (1.25 mmol) of 4-acetoxy-2-methoxycinnamic acid was obtained as white crystals at 187.1 to 193.4 ° C (yield 28%). 1 H-NMR (DMSOd 6 , TMS, δ) 12.34 (1H, brs), 7.78 (1H, d, J = 16.1Hz), 7.72 (1H, d, J = 8.5
Hz), 6.91 (1H, s), 6.77 (1H, d, J = 8.5Hz), 6.50 (1H, d, J = 1
6.1Hz), 3.85 (3H, s), 2.28 (3H, s) From the second crystal, 399 mg of a mixture of 4-acetoxy-2-methoxycinnamic acid and 4-hydroxy-2-methoxycinnamic acid was obtained. .. Then 399 mg of this mixture and sodium methylate 2
A solution of 00 mg (3.70 mmol) in methanol was stirred with heating for 30 minutes. After cooling, the mixture was acidified by adding saturated aqueous ammonium chloride solution, and then extracted with 20 ml of tetrahydrofuran. After distilling off the solvent with an evaporator, it was dissolved in ether,
A saturated aqueous sodium hydrogen carbonate solution was added and the organic layer was separated. After dilute hydrochloric acid was added to the aqueous layer to make it acidic, the precipitated yellow-green crystals were collected by filtration. This was recrystallized from water-acetone to give 4-yellow as a slightly yellow powder with a melting point of 165.5-167.5 ° C (decomposition).
Hydroxy-2-methoxycinnamic acid (114.6 mg, 0.52 mmol) was obtained (yield: 12% based on 4-acetoxy-2-methoxybenzaldehyde). 1 H-NMR (DMSOd 6 , TMS, δ) 10.12 (1H, brs), 7.73 (1H, d, J = 16.1Hz), 7.49 (1H, d, J = 8.3
Hz), 6.44 (1H, s), 6.40 (1H, d, J = 8.3Hz), 6.29 (1H, d, J = 1
6.1Hz), 3.80 (3H, s)

【0023】実施例3 化粧水型化粧料: (組成) 4-アセトキシ-2-メトキシ桂皮酸エチルエステル 5.0(重量%) グリセリン 4.0 ポリオキシエチレン硬化ヒマシ油 1.5 エタノール 10.0 ピロリドンカルボン酸ナトリウム 2.0 香料 微量 精製水 残量 合計 100.0[0023] Example 3 lotion cosmetic composition: (composition) 4-acetoxy-2-methoxycinnamic acid ethyl ester 5.0 (wt%) Glycerin 4.0 Polyoxyethylene hardened castor oil 1.5 Ethanol 10.0 sodium pyrrolidone carboxylate 2.0 Perfume trace Purified Total water remaining 100.0

【0024】実施例4 オイルエッセンス型化粧料: (組成) 4-アセトキシ-2-メトキシ桂皮酸エチルエステル 5.0(重量%) ミンク油 55.0 小麦胚芽油 40.0 合計 100.0Example 4 Oil Essence Type Cosmetic: (Composition) 4-Acetoxy-2-methoxycinnamic acid ethyl ester 5.0 (wt%) Mink oil 55.0 Wheat germ oil 40.0 Total 100.0

【0025】実施例5 W/O型モイスチャークリーム型化粧料: (組成) 4-アセトキシ-2-メトキシ桂皮酸 5.0(重量%) ワセリン 6.0 コレステロール 0.6 セタノール 0.5 ソルビタンセスキオレート 2.0 液状ラノリン 4.0 イソプロピルパルミテート 8.0 スクワレン 10.0 固型パラフィン 4.0 ブチルパラベン 0.1 メチルパラベン 0.1 グリセリン 3.0 香料 0.2 精製水 バランス 合計 100.0Example 5 W / O type moisture cream type cosmetic composition: (Composition) 4-acetoxy-2-methoxycinnamic acid 5.0 (wt%) Vaseline 6.0 Cholesterol 0.6 Cetanol 0.5 Sorbitan sesquioleate 2.0 Liquid lanolin 4.0 Isopropyl palmitate 8.0 Squalene 10.0 Solid paraffin 4.0 Butylparaben 0.1 Methylparaben 0.1 Glycerin 3.0 Perfume 0.2 Purified water Balance 100.0

【0026】実施例6 O/W型モイスチャークリーム型化粧料: (組成) 4-ヒドロキシ-2-メトキシ桂皮酸エチルエステル 5.0(重量%) ステアリン酸 2.0 セタノール 4.0 ワセリン 5.0 スクワレン 8.0 硬化パーム油 4.0 ポリオキシエチレンソルビタンモノステアレート(20E.O.) 1.4 親油型モノステアリン酸グリセリン 2.4 ブチルパラベン 0.1 メチルパラベン 0.1 グリセリン 3.0 ジプロピレングリコール 3.0 L-アルギニン10.0(%)水酸化カリウム 0.2 香料 0.2 精製水 バランス 合計 100.0Example 6 O / W type moisturizing cream type cosmetic composition: (composition) 4-hydroxy-2-methoxycinnamic acid ethyl ester 5.0 (% by weight) stearic acid 2.0 cetanol 4.0 vaseline 5.0 squalene 8.0 hardened palm oil 4.0 polyoxy Ethylene sorbitan monostearate (20E.O.) 1.4 Lipophilic glyceryl monostearate 2.4 Butylparaben 0.1 Methylparaben 0.1 Glycerin 3.0 Dipropylene glycol 3.0 L-Arginine 10.0 (%) Potassium hydroxide 0.2 Perfume 0.2 Purified water Balance total 100.0

【0027】実施例7 乳液型化粧料: (組成) 4-ヒドロキシ-2-メトキシ桂皮酸エチルエステル 5.0(重量%) ステアリン酸 1.0 セタノール 2.0 ワセリン 2.5 スクワレン 4.0 硬化パーム油 2.0 ポリオキシエチレンソルビタンモノステアレート(20E.O.) 1.4 親油型モノステアリン酸グリセリン 1.2 ブチルパラベン 0.1 メチルパラベン 0.1 グリセリン 3.0 ジプロピレングリコール 3.0 水酸化カリウム 0.2 カルボキシビニルポリマー 0.2 香料 0.2 精製水 バランス 合計 100.0Example 7 Emulsion type cosmetic composition: (Composition) 4-hydroxy-2-methoxycinnamic acid ethyl ester 5.0 (% by weight) Stearic acid 1.0 Cetanol 2.0 Vaseline 2.5 Squalene 4.0 Hardened palm oil 2.0 Polyoxyethylene sorbitan monostearate (20E.O.) 1.4 Lipophilic glycerin monostearate 1.2 Butylparaben 0.1 Methylparaben 0.1 Glycerin 3.0 Dipropylene glycol 3.0 Potassium hydroxide 0.2 Carboxyvinyl polymer 0.2 Perfume 0.2 Purified water Balance 100.0

【0028】実施例8 パック型化粧料(ペースト状ピールオフタイプ): (組成) 4-ヒドロキシ-2-メトキシ桂皮酸 10.0(重量%) ポリビニルアルコール 12.0 カルボキシメチルセルロースナトリウム 3.0 ジプロピレングリコール 2.0 グリセリン 2.0 エタノール 5.0 オリーブ油 3.0 ポリオキシエチレン硬化ヒマシ油(30E.O.) 0.5 酸化チタン 8.0 カオリン 6.0 香料 0.1 メチルパラベン 0.1 精製水 バランス 合計 100.0Example 8 Pack-type cosmetic (paste peel-off type): (Composition) 4-hydroxy-2-methoxycinnamic acid 10.0 (% by weight) Polyvinyl alcohol 12.0 Sodium carboxymethyl cellulose 3.0 Dipropylene glycol 2.0 Glycerin 2.0 Ethanol 5.0 Olive oil 3.0 Polyoxyethylene hydrogenated castor oil (30E.O.) 0.5 Titanium oxide 8.0 Kaolin 6.0 Perfume 0.1 Methylparaben 0.1 Purified water Balance 100.0

【0029】実施例9 軟膏型化粧料: (組成) 4-アセトキシ-2-メトキシ桂皮酸エチルエステル 10.0(重量%) 白色ワセリン 90.0 合計 100.0Example 9 Ointment Cosmetic: (Composition) 4-Acetoxy-2-methoxycinnamic acid ethyl ester 10.0 (wt%) White petrolatum 90.0 Total 100.0

【0030】実施例10 液剤型化粧料: (組成) 4-アセトキシ-2-メトキシ桂皮酸エチルエステル 5.0(重量%) エタノール 95.0 合計 100.0Example 10 Liquid formulation cosmetics: (Composition) 4-acetoxy-2-methoxycinnamic acid ethyl ester 5.0 (wt%) ethanol 95.0 Total 100.0

【0031】試験例1 マウス背部皮膚毛包器官培養系のチロシナーゼ活性によ
る評価 試験方法:メラニン合成を盛んに行っている生後8〜11
日のC57BL系マウスの背部毛包を3〜4日間培養した。
培養中の培養液に評価サンプルを最終濃度5mMになるよ
うに添加し、メラニン合成を担う酵素・チロシナーゼ活
性を3,5-3H-チロシンからの遊離トリチウム量(3HOH)
により測定し、コントロールと比較し評価した。その結
果を表1に示す。 抑制効果 なし 0 0〜5% ± 5〜35% + 35%〜 ++ 結果:
Test Example 1 Evaluation of mouse dorsal skin hair follicle organ culture system by tyrosinase activity Test method: 8-11 after birth in which melanin synthesis is actively carried out
The dorsal hair follicles of C57BL mice for 3 days were cultured for 3 to 4 days.
The evaluation sample was added to the culture solution during culturing so that the final concentration was 5 mM, and the enzyme responsible for melanin synthesis, tyrosinase activity, was released from 3,5- 3 H-tyrosine to release tritium ( 3 HOH).
Was evaluated by comparing with the control. The results are shown in Table 1. No suppression effect 0-5% ± 5-35% +35%-++ Result:

【0032】[0032]

【表1】 [Table 1]

【0033】試験例2 後天的なメラニン色素斑形成能を有する褐色モルモット
を実験動物として用い、色素沈着を形成後、色素沈着に
対する退色改善効果を調べた。 試験方法:褐色モルモット(皮膚色が黄色人種のものと
類似し、人間と同様紫外線の照射後約4日で色素斑が生
じ始め、約8日間に最も黒化するモルモット)を用い、
該モルモットの背部毛をバリカンにて刈毛し、更に電気
カミソリにて剃毛した。このモルモットに8-メトキシソ
ラレン(PUVA)を腹腔内投与後、UVA(BLBランプ,3.1m
W/cm2)を5分間照射した。照射15日後より、生じたPUV
A色素斑形成部位に評価サンプル(4-アセトキシ-2-メト
キシ桂皮酸エチルエステル)の5%溶液(エタノール80
%,水20%)を1日2回計30日間連続して塗布した。皮
膚色の黒化度は以下に示す判定規準にて肉眼判定し、評
価点を平均しその効果を測定した。この結果を表2に示
す。 判定規準 0:色素沈着を認めない。 1:境界不明瞭なわずかな色素沈着を認める。 2:境界明瞭な中程度の色素沈着を認める。 3:境界明瞭な強度の色素沈着を認める。 結果:
Test Example 2 A brown guinea pig having an acquired ability to form melanin pigment spots was used as an experimental animal, and after the formation of pigmentation, the effect of improving fading on pigmentation was examined. Test method: Using a brown guinea pig (a guinea pig whose skin color is similar to that of a human race of yellow color, pigmented spots start to appear about 4 days after irradiation of ultraviolet rays like humans, and turn black most in about 8 days).
The back hair of the guinea pig was shaved with a hair clipper and then shaved with an electric razor. After 8-methoxypsoralen (PUVA) was intraperitoneally administered to this guinea pig, UVA (BLB lamp, 3.1 m
W / cm 2 ) was irradiated for 5 minutes. PUV generated from 15 days after irradiation
A sample (4-acetoxy-2-methoxycinnamic acid ethyl ester) 5% solution (ethanol 80
%, Water 20%) was applied twice a day continuously for a total of 30 days. The degree of blackening of the skin color was visually evaluated according to the following criteria, and the evaluation points were averaged to measure the effect. The results are shown in Table 2. Criteria 0: No pigmentation is observed. 1: A slight pigmentation with unclear boundaries is observed. 2: Medium pigmentation with clear boundaries is recognized. 3: Clearly marked strong pigmentation is observed. result:

【0034】[0034]

【表2】 [Table 2]

【0035】[0035]

【発明の効果】本発明の美白化粧料は、色素沈着改善効
果に優れ、予め日焼けを防止する従来のサンスクリーン
剤等とは異なり、皮膚のしみ、そばかす、日焼け後の色
素沈着部に局所的に適用することにより、該部位を治療
・改善し、正常な皮膚色に戻すことができるものであ
る。また、有効成分である本発明の桂皮酸エステル誘導
体(1)は、皮膚に対する刺激性、アレルギーの発現等が
認められず、本発明の美白化粧料は安全性の高いもので
ある。
EFFECTS OF THE INVENTION The whitening cosmetic composition of the present invention has an excellent pigmentation improving effect and is different from the conventional sunscreen agents etc. which prevent sunburn in advance, and is locally applied to the spots on the skin, freckles, and the pigmented portion after sunburn. It is possible to treat and improve the area and restore the normal skin color by applying In addition, the cinnamic acid ester derivative (1) of the present invention, which is an active ingredient, has no irritation to the skin, expression of allergies, etc., and thus the whitening cosmetic composition of the present invention is highly safe.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 // C07C 59/52 8827−4H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location // C07C 59/52 8827-4H

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1) 【化1】 (式中、R1は水素原子または低級アシル基を、R2は低
級アルキル基を、R3は水素原子または低級アルキル基
を示す)で表わされる桂皮酸誘導体を有効成分とする美
白化粧料。
1. A general formula (1): A whitening cosmetic composition containing a cinnamic acid derivative represented by the formula (wherein R 1 represents a hydrogen atom or a lower acyl group, R 2 represents a lower alkyl group, and R 3 represents a hydrogen atom or a lower alkyl group) as an active ingredient.
【請求項2】 一般式(2) 【化2】 (式中、R1′は低級アシル基を、R2は低級アルキル基
を、R3は水素原子または低級アルキル基を示す)で表
わされる桂皮酸誘導体。
2. A general formula (2): (In the formula, R 1 ′ is a lower acyl group, R 2 is a lower alkyl group, and R 3 is a hydrogen atom or a lower alkyl group).
JP26640891A 1991-10-15 1991-10-15 Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component Pending JPH05105643A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26640891A JPH05105643A (en) 1991-10-15 1991-10-15 Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26640891A JPH05105643A (en) 1991-10-15 1991-10-15 Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component

Publications (1)

Publication Number Publication Date
JPH05105643A true JPH05105643A (en) 1993-04-27

Family

ID=17430521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26640891A Pending JPH05105643A (en) 1991-10-15 1991-10-15 Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component

Country Status (1)

Country Link
JP (1) JPH05105643A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246328A (en) * 1997-12-19 1999-09-14 L'oreal Sa Use of phloroglucinol in cosmetic
JPH11246333A (en) * 1997-12-19 1999-09-14 L'oreal Sa Use of cinnamic acid or its derivative in astringent cosmetic
JPH11246332A (en) * 1997-12-19 1999-09-14 L'oreal Sa Use of cinnamic acid or its derivative in cosmetic
WO2003022978A1 (en) * 2001-09-11 2003-03-20 The Procter & Gamble Company Compositions comprising photo-labile
US6660283B2 (en) 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
WO2008018683A1 (en) * 2006-08-10 2008-02-14 Amorepacific Corporation Hydroxycinnamic acid derivatives and preparation method thereof and cosmetic composition containing it
CN102557903A (en) * 2012-01-13 2012-07-11 浙江龙华精细化工有限公司 Preparation method of 4-hydroxyl-2-methoxybenzaldehyde

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246328A (en) * 1997-12-19 1999-09-14 L'oreal Sa Use of phloroglucinol in cosmetic
JPH11246333A (en) * 1997-12-19 1999-09-14 L'oreal Sa Use of cinnamic acid or its derivative in astringent cosmetic
JPH11246332A (en) * 1997-12-19 1999-09-14 L'oreal Sa Use of cinnamic acid or its derivative in cosmetic
US6054137A (en) * 1997-12-19 2000-04-25 Societe L'oreal S.A. Promoting epidermal renewal with phloroglucinol
US6264962B1 (en) 1997-12-19 2001-07-24 Societe L'oreal S.A. Use of cinnamic acid or of at least one of its derivatives in a cosmetic composition
US6267971B1 (en) 1997-12-19 2001-07-31 Societe L'oreal S.A. Use of cinnamic acid or of its derivatives in a cosmetic firming composition
US6660283B2 (en) 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
WO2003022978A1 (en) * 2001-09-11 2003-03-20 The Procter & Gamble Company Compositions comprising photo-labile
US7071151B2 (en) 2001-09-11 2006-07-04 Procter & Gamble Company Compositions comprising photo-labile perfume delivery
WO2008018683A1 (en) * 2006-08-10 2008-02-14 Amorepacific Corporation Hydroxycinnamic acid derivatives and preparation method thereof and cosmetic composition containing it
CN102557903A (en) * 2012-01-13 2012-07-11 浙江龙华精细化工有限公司 Preparation method of 4-hydroxyl-2-methoxybenzaldehyde

Similar Documents

Publication Publication Date Title
JPH05213729A (en) Melamine-inhibitor
JPH05105643A (en) Cinnamic acid derivative and skin-beautifying cosmetic containing the derivative as active component
JPH05105621A (en) Beautifying cosmetic comprising cinnamic ester derivative as active ingredient
JP3071990B2 (en) External preparation for skin
WO1997041825A1 (en) Cosmetic
JPH06321764A (en) Skin beautifying agent
JPH05105620A (en) Beautifying cosmetic comprising p-hydroxycinnamic acid derivative as active ingredient
JPH09132527A (en) Suppressant for melanogenesis and dermal preparation for external use
JPH0977651A (en) Beautifying and whitening cosmetic
JPH05345713A (en) External preparation for skin
JPH0632727A (en) External preparation for skin
JPH06172150A (en) Skin cosmetic
JPH09124474A (en) Suppressant for melanogenesis and dermal preparation for external use
JPH08283114A (en) Skin lightener
JPH0853332A (en) Whitening cosmetic
JPH0848621A (en) Skin whitening cosmetic
JPH07330569A (en) Beautifying cosmetic
JPH08333232A (en) Whitening agent
JPH06227958A (en) External agent for skin
JPH06128203A (en) Skin external preparation
JPH0987127A (en) Skin-lightening agent and skin preparation for external use containing the same
JPH05213857A (en) Melanin inhibitor
JPH08175959A (en) Skin cosmetic
JPH08283119A (en) Skin lightener
JPH08333235A (en) Whitening agent